HyBrid Lymphedema Surgery in the Austrian Insurance System
Chieh-Han John Tzou, MD, MBA Director of the Department of Plastic and Reconstructive Surgery, Hospital of Divine SaviorSeptember 29, 2025
Bringing to Light the Invisible
Dhruv Singhal, MD Associate Professor of Surgery, Harvard Medical SchoolAugust 22, 2025
Clinical and Translational Prevention of Lymphedema
Aladdin Hassanein, MD, MMSc, FACS Associate Professor & Director of Research, Indiana University School of MedicineJuly 14, 2025
Unlocking the Mysteries of Lymphatic
Malformations: Understanding Symptoms, Causes, and Effective Treatments
Michael Kelly, MD, PhD
Executive Director, Lymphangiomatosis & Gorham’s Disease Alliance (LGDA)
May 14, 2025
Drug-repurposing in lymphedema research – using reverse
translation to identify tangible pharmacological approaches
Epameinondas Gousopoulos, MD, PhD
Head, Researcher Lab
May 12, 2025
The Only Way to Treat Lymphedema is Through a Multidisciplinary Approach
Tim Decock, PT, ET, MT CEO, Decockliniek Belgium & Lymph House AntwerpApril 08, 2025
Better Research & Health Care with Patients &
Next-of-kin Collaboration
Margareta Haag & Mikaela Friedman, PhD
Collaborators, Patient Advocacy
February 17, 2025
Finding a Drug to Treat Lymphedema: An Update
Stanley Rockson, MD Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University School of MedicineJanuary 26, 2025
GLP-1 Receptor Agonists are not Just for Weight Loss
Can They Help Prevent and Treat Lymphedema?
Joseph Dayan, MD
Reconstructive Surgeon, Institute for Lymphatic Surgery and Innovation
December 10, 2024
Building a Comprehensive Lymphedema Program in a Rural Area
Stefanos Boukovalas, MD Reconstructive Surgeon, University of Tennessee Medical CenterNovember 20, 2024